TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
NTRA

Natera Inc

Healthcare · Diagnostics & Research

370.60$ +0.3% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow NTRA
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-460.6% +58.7%
+7.5% +11.6% +15.7% +5.0% +3.1% +11.4% +30.7% +48.4% +44.3% +28.5% +40.4%
+42.1% +44.7% +7.6% +24.5% +101.6% +75.3% +129.7% +32.3% +25.9% +43.1% +29.1%
+157.7% -13.3% -26.8% +74.1% -14.0% +229.2% +165.5% +8.5%
+172.6% -75.0% +739.5% +38.5% +0.2% -243.9% +369.2%
-21.1% +194.7% -57.4% -60.7% +28.0% +294.6% +109.3% +16.2% -17.8% +69.5% +59.9%
+2,019.1% -70.7% -137.4% +5,060.9% +24.4% -38.1% -49.0% -18.3% -196.1%
-100.0%
+106,522.9% -98.6% +29.2% +8.2% +19.5% +64.6% +90.5% -3.8% +16.0% +14.3%
+236.4% -20.7% +967.3% +167.1% +0.0% +0.0% -85.0% +0.0% -100.0% -100.0%
+239.0% -93.1% +509.6% +41.5% +199.6% +47.0% +15.0% -16.2% -47.3% -88.1% +57.1%
-202.7% -71.1% -219.6% +966.8% -53.9% +72.4% -57.0%
-8,671.1% +57.6%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?